| Current Price | $2.18 | Mkt Cap | $208.0M |
|---|---|---|---|
| Open | $2.08 | P/E Ratio | -7.29 |
| Prev. Close | $2.18 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.07 - $2.21 | Volume | 338,373 |
| 52-Wk Range | $1.47 - $3.90 | Avg. Daily Vol. | 1,577,624 |
The Company is dedicated to developing and commercializing drugs for infectious diseases.
| Current Price | $2.18 | Mkt Cap | $208.0M |
|---|---|---|---|
| Open | $2.08 | P/E Ratio | -7.29 |
| Prev. Close | $2.18 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.07 - $2.21 | Volume | 338,373 |
| 52-Wk Range | $1.47 - $3.90 | Avg. Daily Vol. | 1,577,624 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about IMMP.
Find the members with the highest scoring picks in IMMP.
cfayles (< 20) Score: +260.23
The Score Leader is the player with the highest score across all their picks in IMMP.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| cfayles | < 20 | 10/17/2007 |
|
5Y | $7.65 | -71.50% | +188.72% | +260.23 | 0 Comment | |
| Danielwmartin1 | < 20 | 6/24/2021 |
|
1Y | $4.06 | -46.31% | +0.40% | +46.71 | 0 Comment | |
| wsmoot8796 | 76.66 | 7/14/2022 |
|
1Y | $2.04 | +6.86% | +14.32% | +7.45 | 0 Comment | |
| LifeScientist | 22.91 | 9/22/2021 |
|
5Y | $3.71 | -41.24% | -2.05% | -39.19 | 0 Comment | |
| Hobooda | < 20 | 5/24/2021 |
|
5Y | $4.65 | -53.12% | +2.34% | -55.46 | 0 Comment | |
| RDCOMER | 55.71 | 6/4/2007 |
|
3M | $7.14 | -69.47% | +194.08% | -263.55 | 0 Comment | |
| pinksheetbasher | 30.00 | 8/22/2007 |
|
NS | $7.45 | -70.74% | +208.10% | -278.83 | 0 Comment | |
| Boliche | 63.08 | 12/15/2006 |
|
3M | $8.57 | -74.56% | +217.42% | -291.98 | 0 Comment | |
| jrshan | < 20 | 12/21/2006 |
|
3W | $9.02 | -75.83% | +218.63% | -294.46 | 0 Comment | |
| Mitchell377 | < 20 | 12/19/2006 |
|
3M | $9.30 | -76.56% | +220.54% | -297.10 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
